Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 63414 record(s)

Req # A-2021-002137

Adverse Drug Reaction (ADR). Report number: 000977590.

Organization: Health Canada

2 page(s)
May 2022

Req # A-2021-002149

Adverse Drug Reactions (ADRs) for BISACODYL. Report numbers: E2B_04825443, E2B_04699223, E2B_04892483, E2B_04949285.

Organization: Health Canada

229 page(s)
May 2022

Req # A-2022-000012

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-102130-986.

Organization: Health Canada

4 page(s)
May 2022

Req # A-2022-000077

Adverse Drug Reactions (ADRs). Report numbers: 000979106, 000980921, 000982354, 000982468, 000982472, 000982492, 000982509, 000982513.

Organization: Health Canada

47 page(s)
May 2022

Req # A-2022-000091

Adverse Drug Reactions (ADRs) for ZOPICLONE, FUROSEMIDE. Report numbers: 000980710, 000982208.

Organization: Health Canada

10 page(s)
May 2022

Req # A-2022-000092

Adverse Drug Reaction (ADR) for Finasteride. Report number: 000938293. ADR for Nitrofurantoin. Report number: 000959174.

Organization: Health Canada

12 page(s)
May 2022

Req # A-2022-000102

Adverse Drug Reaction (ADR) for CANCIDAS. Report number: E2B_02706392.

Organization: Health Canada

11 page(s)
May 2022

Req # A-2022-000111

Adverse Drug Reaction (ADR). Report number: 000976770.

Organization: Health Canada

7 page(s)
May 2022

Req # A-2022-000161

Adverse Drug Reaction (ADR) for Ramipril. Report number: 000943180. ADR for Citalopram. Report number: 000950747. ADR for Telmisartan. Report number: 000942789.

Organization: Health Canada

12 page(s)
May 2022

Req # A-2022-000204

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-104169-513.

Organization: Health Canada

10 page(s)
May 2022
Date modified: